Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has issued an announcement.
PharmaCorp Rx Inc. has secured new credit facilities totaling up to $20.5 million from CIBC, which will support its acquisition strategy and operational expansion. Additionally, a $5 million credit facility has been established to facilitate the Pharmacist Co-Ownership Program, enabling pharmacists to acquire ownership stakes in the pharmacies they work at, thus promoting local ownership and long-term wealth creation.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates in the pharmaceutical industry, focusing on acquiring and managing pharmacies under the PharmaChoice Canada banner. The company is involved in strategic alliances to expand its operations and actively seeks to acquire both PharmaChoice-branded and independently owned pharmacies across Canada.
Average Trading Volume: 30,145
Technical Sentiment Signal: Buy
Current Market Cap: C$53.61M
For an in-depth examination of PCRX stock, go to TipRanks’ Overview page.